# Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients

> **NCT02022995** · — · COMPLETED · sponsor: **National Taiwan University Hospital** · enrollment: 180 (actual)

## Conditions studied

- Colon Cancer Adenocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02022995
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2016-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02022995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02022995, "Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02022995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*